Chiara Scelfo

568 total citations
19 papers, 314 citations indexed

About

Chiara Scelfo is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Chiara Scelfo has authored 19 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 5 papers in Surgery. Recurrent topics in Chiara Scelfo's work include Asthma and respiratory diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Respiratory and Cough-Related Research (4 papers). Chiara Scelfo is often cited by papers focused on Asthma and respiratory diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Respiratory and Cough-Related Research (4 papers). Chiara Scelfo collaborates with scholars based in Italy and Denmark. Chiara Scelfo's co-authors include Francesco Menzella, Nicola Facciolongo, Carla Galeone, Giulia Ghidoni, Matteo Fontana, Patrizia Ruggiero, Francesco Livrieri, Roberto Piro, Francesca Bertolini and Marco Caminati and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care and BioMed Research International.

In The Last Decade

Chiara Scelfo

18 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Scelfo Italy 12 147 119 64 52 52 19 314
Tobias Veit Germany 9 149 1.0× 80 0.7× 32 0.5× 27 0.5× 75 1.4× 24 283
Claudia Castagnetti Italy 11 216 1.5× 183 1.5× 51 0.8× 43 0.8× 11 0.2× 16 325
Eman Mahmoud Fouda Egypt 11 89 0.6× 56 0.5× 51 0.8× 13 0.3× 29 0.6× 36 281
Teyfik Turgut Türkiye 11 142 1.0× 112 0.9× 97 1.5× 8 0.2× 82 1.6× 25 360
Khadija Boussetta Tunisia 10 63 0.4× 40 0.3× 76 1.2× 13 0.3× 65 1.3× 41 345
Misbahuddin Khaja United States 11 105 0.7× 26 0.2× 31 0.5× 44 0.8× 47 0.9× 60 290
Levent Tabak Türkiye 9 67 0.5× 55 0.5× 101 1.6× 38 0.7× 66 1.3× 24 263
Joanna Peradzyńska Poland 9 163 1.1× 103 0.9× 22 0.3× 7 0.1× 88 1.7× 20 283
Ajmal Khan India 11 412 2.8× 240 2.0× 230 3.6× 8 0.2× 40 0.8× 37 526
Yangjin Jegal South Korea 11 444 3.0× 118 1.0× 74 1.2× 16 0.3× 114 2.2× 48 591

Countries citing papers authored by Chiara Scelfo

Since Specialization
Citations

This map shows the geographic impact of Chiara Scelfo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Scelfo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Scelfo more than expected).

Fields of papers citing papers by Chiara Scelfo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Scelfo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Scelfo. The network helps show where Chiara Scelfo may publish in the future.

Co-authorship network of co-authors of Chiara Scelfo

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Scelfo. A scholar is included among the top collaborators of Chiara Scelfo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Scelfo. Chiara Scelfo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Magnani, L., Federica Lumetti, Chiara Scelfo, et al.. (2023). One‐year clinical experience on the use of Nintedanib in systemic sclerosis. SHILAP Revista de lepidopterología. 11(6). e01120–e01120.
2.
Menzella, Francesco, Matteo Fontana, Marco Contoli, et al.. (2022). Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life. Journal of Asthma and Allergy. Volume 15. 505–515. 15 indexed citations
3.
Facciolongo, Nicola, Martina Bonacini, Carla Galeone, et al.. (2022). Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling. Allergy Asthma and Clinical Immunology. 18(1). 39–39. 10 indexed citations
4.
Menzella, Francesco, Carla Galeone, Giulia Ghidoni, et al.. (2021). Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab. Multidisciplinary Respiratory Medicine. 16(1). 779–779. 13 indexed citations
5.
Menzella, Francesco, Matteo Fontana, Carla Galeone, et al.. (2021). A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM). Journal of Asthma and Allergy. Volume 14. 1019–1031. 13 indexed citations
6.
Menzella, Francesco, Matteo Fontana, Carla Galeone, et al.. (2021). Real world effectiveness of benralizumab on respiratory function and asthma control. Multidisciplinary Respiratory Medicine. 16(1). 785–785. 10 indexed citations
7.
Piro, Roberto, et al.. (2021). Lung "holes" after cryobiopsy: a case report. BMC Pulmonary Medicine. 21(1). 274–274. 2 indexed citations
8.
Scelfo, Chiara, Francesco Menzella, Matteo Fontana, et al.. (2021). Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines. 9(5). 420–420. 52 indexed citations
9.
Menzella, Francesco, Chiara Barbieri, Matteo Fontana, et al.. (2021). Effectiveness of noninvasive ventilation in COVID‐19 related‐acute respiratory distress syndrome. The Clinical Respiratory Journal. 15(7). 779–787. 36 indexed citations
10.
Menzella, Francesco, et al.. (2021). Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab. Biomedicines. 9(4). 348–348. 11 indexed citations
11.
Menzella, Francesco, Andrea Matucci, Alessandra Vultaggio, et al.. (2020). COVID-19: general overview, pharmacological options and ventilatory support strategies. Multidisciplinary Respiratory Medicine. 15(1). 708–708. 2 indexed citations
12.
Menzella, Francesco, Patrizia Ruggiero, Giulia Ghidoni, et al.. (2020). <p>Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights</p>. Journal of Asthma and Allergy. Volume 13. 301–313. 17 indexed citations
13.
Menzella, Francesco, Matteo Fontana, Carlo Salvarani, et al.. (2020). Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation. Critical Care. 24(1). 589–589. 46 indexed citations
14.
Scelfo, Chiara, Matteo Fontana, Francesco Menzella, et al.. (2020). <p>A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports</p>. Therapeutics and Clinical Risk Management. Volume 16. 1039–1046. 17 indexed citations
15.
Menzella, Francesco, Patrizia Ruggiero, Carla Galeone, et al.. (2020). Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma. Pulmonary Pharmacology & Therapeutics. 64. 101966–101966. 16 indexed citations
16.
Menzella, Francesco, Francesca Bertolini, Mirella Biava, et al.. (2018). Severe refractory asthma: current treatment options and ongoing research. Drugs in Context. 7. 1–15. 20 indexed citations
17.
Galeone, Carla, Chiara Scelfo, Francesca Bertolini, et al.. (2018). Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?. BioMed Research International. 2018. 1–15. 22 indexed citations
18.
Scelfo, Chiara, Chiara Longo, Marina Aiello, et al.. (2018). Pulmonary hernia: Case report and review of the literature. Respirology Case Reports. 6(8). e00354–e00354. 5 indexed citations
19.
Crisafulli, Ernesto, Chiara Scelfo, Panagiota Tzani, et al.. (2017). Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation. European Journal of Preventive Cardiology. 24(9). 990–999. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Veit Breakdown of academic impact, for papers by Claudia Castagnetti Breakdown of academic impact, for papers by Eman Mahmoud Fouda Breakdown of academic impact, for papers by Teyfik Turgut Breakdown of academic impact, for papers by Khadija Boussetta Breakdown of academic impact, for papers by Misbahuddin Khaja Breakdown of academic impact, for papers by Levent Tabak Breakdown of academic impact, for papers by Joanna Peradzyńska Breakdown of academic impact, for papers by Ajmal Khan Breakdown of academic impact, for papers by Yangjin Jegal
Rankless by CCL
2026